Another cross-post from the Big Thread:


[link to thehill.com (secure)]
(<50%)

Vaccine developers will not have to conduct lengthy clinical trials to evaluate the effectiveness of shots tailored to fight new coronavirus variants, according to new guidance from the Food and Drug Administration (FDA).

According to the guidance released Monday, developers will not need large randomized control trials comparing it to a placebo.

Instead, the FDA said it recommended companies submit data from small trials comparing a person's immune response to a vaccine that has already been authorized.



BUT FOR IVERMECTIN...
we can't possibly use it because there aren't enough double-blind randomised control trials... despite it being used for 40 yrs in the wild already... and having basically zero adverse effects compared to vaccines....